Two adipokinetic hormones (AKH I: pGlu-Leu-Asn-Phe-ThrPro-Asn-Trp-Gly-Thr-NH,, and AKH II: pGlu-Leu-Asn-Phe-SerThr-Gly- Trp-NH,) are synthesized by the neurosecretory cells of the corpora cardiaca (CC) of the locust Schisfocerca gregaria. Both AKHs are released into the blood during flight and serve to regulate lipid metabolism and other physiological processes involved in flight. By in vitro "pulse-chase" experiments we show that 2 precursors (PI and P2) are involved in AKH biosynthesis.
These are about 8.4 kDa polypeptides which are AKH immunoreactive but also contain an amino acid (tyrosine) not present in the AKH peptides. By following the fate of '%-tyrosine incorporated into Pi and P2, we have identified 2 novel products of precursor processing. These are called AKH-Precursor
Related Peptides or APRP 1 and APRP 2. Size exclusion chromatography shows that the APRPs are about 8.5 kDa large and therefore represent major fragments of the precursors. The optical density peaks corresponding to Pl , P2, APRP 1, and APRP 2 on a reverse-phase chromatogram are identified. The precursors being metabolic intermediates are represented by minor optical density peaks that disappear when de nova protein synthesis is blocked by cycloheximide. In contrast, the APRPs are represented by major optical density peaks consistent with their being accumulating end products of AKH precursor processing. The function of the APRPs is as yet unknown. They are, however, co-synthesized and also co-released with the AKHs, and may therefore also have hormonal functions related to flight.
It is now well established that the precursor for a peptide transmitter or hormone may include more than one bioactive amino acid sequence (for reviews, see Lynch and Snyder, 1986; Eipper et al., 1986) . During enzymatic processing of the precursor, different bioactive sequences can therefore be liberated and made available for release. There are few intact tissue systems in which this aspect of peptide biosynthesis can conveniently be studied. One such system is represented by the bag cell cluster of Aplysia. These cells produce the precursor of egg laying hormone (ELH), which upon processing generates ELH and additional peptides that appear to be necessary for the expression of the complete egg laying behavior (Scheller et al., 1983; Mayeri et al., 1985; Sigvardt et al., 1986 ). We have previously described (Hekimi and O'Shea, 1987) another tissue that allows us to study the biosynthesis and identify 2 precursors (Pl and P2) of 2 related insect neuropeptides (the adipokinetic hormones, or AKHs). Here, we identify 2 novel peptides generated from these precursors and characterize them as major fragments of their respective precursors. Our studies were initiated with the adipokinetic hormones (AKH I and AKH II) synthesized by the neurosecretory cells of the glandular lobes of the corpora cardiaca (CC) of the locust Schistocerca gregaria. The CC are paired neurosecretory glands located in the head in close proximity to the brain, by which they are innervated. In the adult locust the AKI-I peptides are released just after the initiation of flight. This results in a mobilization of lipid metabolism, which provides the energy for migratory flight. The amino acid sequence of AKH I is pGluLeu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH, (Stone et al., 1976) and for AKH II pGlu-Leu-Asn-Phe-Ser-Thr-Gly-Tip-NH, (Siegert et al., 1985) . These hormones are major products of the neurosecretory cells of the locust CC. The CC (about 0.1 mg wet weight) contain as much as 1 nmol AKH I and 0.2 nmol AKH II. This remarkable tissue therefore provides an unusually good system for the analysis of the synthesis of neuropeptides.
Synthesis of AKH I and AIUI II can be studied by providing radiolabeled amino acids to CC maintained in short-term tissue culture (Hekimi and O'Shea, 1987) . By following the incorporation of 3H-tryptophan, we showed that label is first incorporated in 2 polypeptides called Pl and P2 prior to its appearance in AKH I and II. On the basis ofthis observation and by showing that Pl and P2 are AM-immunoreactive, we identified them as precursors of the AKHs. In addition, we found that biosynthetically labeled PI and P2 and their AKH immunoreactivity co-migrated with 2 major optical density (OD) peaks detected using reverse-phase chromatography. This led us to believe that the 2 OD peaks were due to the presence of relatively large amounts of the AKH precursors. In this respect, we were wrong. We show here that P 1 and P2 and their AKH immunoreactivity can be separated from the major OD peaks. Relatively small optical density peaks are now assigned to the precursors, consistent with Pl and P2 being nonaccumulating intermediates of AKH biosynthesis. We show now that the large OD peaks are produced by 2 major fragments of the precursors, generated during processing. They accumulate in the CC in amounts comparable to the amounts of the AKHs. We have named these newly identified products Adipokinetic hormone-Precursor Related Peptides, or APRPs. Although derived from the AKH precursors, the APRPs are themselves neither AKH-immuno- P2 (upperpanel) and the AM-like immunoreactivity associated with each fraction of the eluant measured by RIA (lower panel). Note that the peak fraction of the 2 isotopes coelutes for both Pl and P2, and, moreover, the shapes of the peaks defined by the 2 isotopes are the same. The peaks of double-labeled precursors also coelute with the AM-like immunoreactivity.
In this experiment each fraction was split in 2 parts, one being subjected to RIA corresponding to 25 CC and the other was monitored for 3H-and 14C-decays.
reactive nor do they contain tryptophan.
While their function is unknown, their synthesis is coupled to that of the AKHs, and we show that they are released with them. The APRPs might therefore be hormones with activities that complement those of the AKHs (see Discussion).
Materials and Methods
Animals. Both male and female adult specimens of the locust Schistocerca gregaria were used in our experiments. They were reared in our own laboratory culture. Female New Zealand White Rabbits produced the antiserum to a synthetic analog of AKH I.
Preparation of AkTH antiserum and radioimmunoassay procedures. To generate an antiserum to the precursor form of AKH, an analog of the sequence Lys-Tyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-OH was designed and synthesized (Peninsula Laboratories). Details of methods used to generate antisera and those used in the radioimmunoassay (RIA) were eiven in Hekimi and O'Shea (1987) . in which the serum is named IIIa. Here, the tracer for the radioimmunoassay (RIA) was a synthetic analog of the sequence Tyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH, (Peninsula Laboratories). This peptide was radiolabeled on the tyrosine residue with 1251. Activated charcoal was used to precipitate unbound peptide after serum IIIa (diluted 20-fold) was incubated with the tracer and samples. The ability of material from HPLC fractions to displace bound counts was determined.
Organ (CC) culture. Details of in vitro incubation methods were given in Hekimi and O'Shea (1987) . In order to monitor synthesis of the precursors and their products 10 PCi of 'H[side chain 2,3] L-tryptophan (60 Ci/mM) or 10 PCi of L-(UJ4C) tyrosine (500 mCi/mM) or both was added to the incubation saline. Following varying durations of incubation (see Results) with labeled amino acids, the CC were either washed in saline and extracted (see below) or transferred to a large volume (5 ml) of "translation-block" medium. The translation-block medium consisted of saline containing 1 &ml cycloheximide.
Extraction, identification, and purification procedures. Corpora cardiaca were homogenized in 100 ~1 of 0.1% trifluoroacetic acid (TFA) at room temperature with a Branson microprobe ultrasound cell disruptor. The crude TFA-soluble supematant was removed, frozen immediately, and subjected to size-exclusion and or reverse-phase chromatography.
For size fractionation, a 60 cm TSK 2000 SW gel-permeation column (LKB), eluted at 0.5 ml/min with 0.1% TFA containing 15% (vol/vol) acetonitrile was used. The exclusion size of this column is about 50 kDa. Acetonitrile was used to prevent hydrophobic interactions, which can result in anomalous retentions of some peptides and tryptophan. The TSK 2000 column was calibrated according to molecular weight using the following standards: myoglobin (fragment) 14.4 kDa; myoglobin (fragment) 8.2 kDa; myoglobin (fragment) 6.2 kDa; a synthetic _ -28 residue-peptide of 3.2 kDa. Reverse-phase separations of AKH I, AKH II. APRP 1. APRP 2. Pl . and P2 were achieved usina a C, widepore column (Aquapore RP-360; 7 wrn, Pierce Chemical-Company). The column was eluted at 1.5 ml/min with 0.1% TFA and a linear acetonitrile gradient (from 25 to 45% in 10 min). Retention times of synthetic AKH I or II (Peninsula Laboratories) could not be distinguished from those of native unlabeled and native biosynthetically labeled AKH I or II.
Three types of detection systems were used to identify the eluting compounds. On-line detection was provided by a Waters 440 fixedwavelength absorbance detector set at 2 14 nm, which gave an estimate of the relative abundance of peptide bonds. In one experiment (Fig. l) , compounds were detected by RIA and scintillation counting after fractionation of the eluant. For detection of the AKH immunoreactivity, HPLC fractions were evaporated to dryness using a Savant Speed-Vat evaporator and subjected to RIA (see above). For calculation of the isotopic content of HPLC fractions, 'H and 14C B-emissions were distinguished by their respective energies.
Potassium-stimulated calcium-dependent release. The ability of CC to release the APRPs was investigated by superfusing the glands with physiological saline and with salines of altered ionic composition. In order to concentrate released hydrophobic compounds, the glands were placed in a small chamber (Swinny Filter Holder, Millipore) attached above a cartridge containing reverse-phase packing (C,, SepPak, Waters Associate). The superfusate was added above the chamber, and a peri- . Pulse-translation block experiment using reverse-phase chromatography of CC after incubation with W-tyrosine and 3H-tryptophan for 1.5 hr followed by 24 hr block. Left panel, Chromatogram just after the incubation period. Both isotopes are incorporated into both Pl and P2 as indicated by the co-migration of the 'H (above) and 14C (below). Right panel, Chromatogram of CC incubated in cycloheximide for 24 hr after the 1.5 hr pulse labeling. Label Pl and P2 is now transferred to the AKHs (3H) and the APRPs (I%).
staltic pump was used to move it through the chamber and SepPak. Further details of this method for monitoring peptide release have been described (Adams and O'Shea, 1983; O'Shea et al., 1984) . Fifty CC were placed in the chamber and superfused for 1 hr each in succession with 3 types of saline. The first was physiological saline, the second contained no calcium but had elevated potassium concentration (50 mM), and the third had elevated potassium concentration with normal (5 mM) calcium. For each saline condition a new activated SepPak was attached to the chamber. The SepPaks were flushed with distilled water and the trapped peptides eluted in 5 ml of methanol. Following evaporation of the methanol, the samples were analyzed by reverse-phase chromatography for the presence of APRPs.
Results
Identification of 2 AKH-precursor related peptides (APRPs) In vitro incubation of CC with 3H-tryptophan results in the synthesis of 4 major tryptophan-containing peptides. These are AKH I, AKH II, and their precursors Pl and P2 (Hekimi and O'Shea, 1987) . In our previous publication, the AKH-precursor status of Pl and P2 was established by the following criteria. Both Pl and P2 are larger than the AKH peptides and both are synthesized prior to them. By performing pulse-chase or pulsetranslation block experiments, tryptophan incorporated in Pl and P2 can be recovered in AKH I and II. Finally, both Pl and P2 are AKH-immunoreactive, indicating that they contain amino acid sequences related to AKH. In order to investigate whether Pl and P2 could contain peptides other than AKH, we cultured CC in the presence of 3H-tryptophan, an amino acid present in the AKHs and I%-tyrosine, an amino acid not present in the AKHs. Figure 1 shows a C, reverse-phase chromatogram of an extract of CC that was incubated for 1.5 hr with both 3H-tryptophan and 14C-tyrosine. Two peaks labeled with both isotopes (3H and '"C) can be seen. These were identified as Pl and P2 by several criteria. For example, they occur with the expected retention time and amplitudes (the peak of Pl predominates) and both are AKHimmunoreactive (see lower part of Fig. 1) . Note that the 3H and 14C peaks are virtually superposed, indicating that tyrosine, in addition to tryptophan (as shown previously), is incorporated in the AKH precursors. Thus, the processing of Pl and P2 might result in the production of tyrosine-containing peptides, in addition to the AKHs. That this is the case is shown in Figure 2 , in which CC pulselabeled with 3H-tryptophan and 14C-tyrosine are placed in a "translation-block" medium containing cycloheximide. Note that during the brief incubation (1.5 hr) no radiolabeled AKH is found. Following a 24 hr period of translation block, the double-labeled precursors have disappeared and the tritium tryptophan is chased into the 2 AKH peptides, as expected. Transfer of 3H-tryptophan to the 2 AKHs is accompanied by the transfer of 14C-tyrosine into 2 new radiolabeled compounds (APRP 1 and 2) migrating close to the double-labeled precursors (now absent).
The fact that APRP 1 and 2 migrate on a reverse-phase column very close to the Pl and P2 precursors suggests they are similar in hydrophobicity to their parent compounds. This could (top) and then after 4, 12, and 24 hr in the presence of cycloheximide. The figure shows a progressive transfer of W-tyrosine from the larger Ps to the smaller APRPs during translation block. As the double-labeled peak (Pl and P2) disappears the 'H-labeled tryptophan in this peak is transferred to the AKH peptide (not included in these chromatograms) and the 14C-tyrosine is transferred to the APRPs. Thus, the W-tyrosine is shifted progressively to the right (smaller molecular weight). arise if they represent major fragments of the precursors. Sizing of the APRPs confirms this. To investigate the size relationships between the newly identified APRPs and their precursors we first purified Pl , P2, and APRP 1 and 2 by reverse-phase chromatography and then chromatographed them by size exclusion. This is shown in Figure 3 . In this experiment CC were pulse labeled for 1.5 hr with either 3H-tryptophan or W-tyrosine. The tryptophan-labeled PI and P2 were separated and purified by C, reverse-phase HPLC. The glands pulsed with 14C-tyrosine, * Biosynthesis of Insect Neuropepti des however, were transferred to the translation-block medium overnight to allow processing of the pulse-labeled Pl and P2 into the "C-labeled APRPs. These glands were also subjected to C, reverse-phase chromatography and the 2 14C-labeled products (APRP 1 and 2) collected separately. Thus, we produced purified 3H-tryptophan Pl and P2 and purified 14C-tyrosine APRP 1 and APRP 2. These purified compounds were then applied to a size-exclusion column (TSK 2000) in the following way (Fig. 3) . The 3H-labeled Pl was mixed with 14C-labeled APRP 1 and similarly labeled P2 was mixed with labeled APRP 2. The mixtures included the same tissue (CC) equivalent amounts of the 2 compounds (a P and an APRP). This allowed us to see the relative molecular weights of a P and an APRP simultaneously while monitoring the relative contribution made by each to the OD (a measure of relative amounts per gland). Three expectations were confirmed by this experiment. First, the APRPs are smaller than the Ps. Second, the APRPs are only slightly smaller than the Ps, indicating that they are major fragments of their precursors. Third, monitoring of the column eluant at 214 nm shows that the APRPs are present in the CC in much larger amounts than the Ps (see also Fig. 6 ). This is expected because precursors are metabolic intermediates but their products accumulate.
Estimates of sizes were derived from the TSK 2000 column calibrated using polypeptide standards spanning the range from 14.4 to 3.2 kDa (see Materials and Methods). This gave molecular weights of about 8.4 kDa for Pl and P2 and about 6.5 kDa for APRP 1 and APRP 2. Thus, the APRPs represent approximately 80% of the size of their precursors. The difference in size (about 2 kDa) between a P and an APRP allows the precursors to include no more than 2 copies of an AKH peptide (see Discussion).
The separation of the Ps from the APRPs achieved by the TSK 2000 column allowed us, to follow the time dependence of the transfer of 14C-tyrosine from the larger Ps into the smaller APRPs. We exploited the fact that Ps can be double-labeled (with 14C-tyrosine and 3H-tryptophan) and that the tyrosine is transferred to the APRPs after processing. In this way we have been able to show the expected time-dependent transfer of label from precursors (Pl + P2) into the APRPs. This experiment is shown in Figure 4 . The CC were first incubated for 1.5 hr in 'H-tryptophan and 14C-tyrosine, thus labeling PI and P2. Immediately following this incubation, a broad double-labeled peak representing the sum of Pl and P2 is seen by size-exclusion chromatography (Fig. 4, upper panel) . That this broad peak consists of Pl and P2 can be confirmed by collecting this material and rechromatographing it by C, reverse phase. Following the pulse labeling, CC were transferred into the translation-block medium and then sampled periodically. Figure 4 shows the results following periods of 4, 12, and 24 hr in cycloheximide. Since during these periods new translation but not processing is blocked, there is a progressive, time-dependent decline in the double-labeled P 1 + P2 peak. The 3H-tryptophan is transferred to the AKH I and II peptides (Hekimi and O'Shea, 1987 ; not shown in Fig. 4) . The Y-tyrosine of the double-labeled peak is shifted slightly to the right, as tyrosine-labeled APRPs are synthesized. When chromatographed together, APRP 1 is not well resolved from APRP 2, resulting in the bilobed appearance ofthe APRP peak at the end ofthe 24 hr period in cycloheximide (Fig. 4, lower panel) .
OD peaks assigned to Ps and APRPs
The results so far can be summarized by saying that 2 precursors Pl and P2 (about 8.4 kDa) are synthesized and metabolized and processed rapidly in the CC, producing 4 accumulating compounds, AKH I and II (1.1 and 0.8 kDa) and APRP 1 and 2 (each about 6.5 kDa). The APRPs therefore represent large fragments of the Ps, the difference in size being about 1 or 2 AKH peptides. Size considerations suggest that the AKHs and APRPs may be the only accumulating products of AKH-precursor processing in the CC. A reverse-phase chromatogram of a CC extract reflects this simplicity (Fig. 5 ) in which 4 major optical density peaks are seen. In Figure 5 , the optical density peaks marked APRP 1 and APRP 2 co-migrate with the biosynthetically labeled products of Pl and P2 processing (see Fig.  2 ). Note that each APRP is preceded by a very minor optical density peak, barely visible in Figure 5 but more clearly shown in Figure 6 . These peaks were not detected in our previous report (Hekimi and O'Shea, 1987) because the C, column (Watman Protesil 300 A octyl) and conditions used in those experiments did not permit the separation of the smaller from the larger OD peaks. The chromatogram shown in Figure 6 is from a Pearce C, column using a gradient designed to optimize separation in this region (see Materials and Methods). We can now show that the 3H-tryptophan-labeled Pl and P2 do not co-migrate with major OD peaks but with the 2 minor OD peaks. This was to be expected from the results shown in Figure 3 in which significant OD is associated with the APRPs and not the Ps.
If the 2 minor OD peaks co-migrating with biosynthetically labeled precursors are indeed due to the precursors, their amplitudes should be diminished when Pl and P2 are processed under conditions that prevent their continued synthesis. Such conditions are achieved by placing the glands in cycloheximide. So we performed the following experiment. Corpora cardiaca were first incubated in the presence of both 14C-tyrosine and 3H-tryptophan for 1.5 hr. During this brief period the Pl and P2 precursors become double-labeled, as shown previously. The biosynthetically labeled Pl and P2 co-migrate with the 2 minor OD peaks (Fig. 6, left panel) . After pulse labeling some of the . A pulse-translation block experiment using reverse-phase chromatography. In the left panel, Pl and P2 were double-labeled with 3H-tryptophan and I%-tyrosine for a 1.5 hr pulse incubation. Note that the double-labeled precursors do not co-migrate with the major OD peaks but with the minor ones shown above. After 24 hr in cycloheximide (right panel), the double-labeled precursors have disappeared and so have the small OD peaks co-migrating with them. The W-tyrosine peaks are now shifted to the right and each lies under a major OD peak. The lower panel shows that the small OD peaks associated with the Pl and P2 precursors are not diminished after 24 hr in physiological saline without cycloheximide. Note in right panel that only the Pl and P2 associated OD peaks are lost, the third minor peak eluting earlier being unchanged in all panels.
CC were transferred to the translation-block medium for 24 hr. Following this, %-labeled tyrosine no longer co-migrates with Pl and P2 but is shifted to the right to lie under the larger OD peaks produced by the APRPs (Fig. 6, right panel) . This result was expected from previous experiments (Fig. 2) . Note that the 3H-tryptophan is no longer present because it has been transferred to the AKHs (not shown in Fig. 6 ). The new finding shown here is that the disappearance of label from Pl and P2, indicating complete processing of available precursor pool, is accompanied by the disappearance of the small OD peaks. Thus, in conditions under which new precursor synthesis is prevented, the small OD peaks behave like the biosynthetically labeled precursor peaks, that is, they are "chased out." In a control experiment, some of the glands that received the double-labeled pulse were washed and transferred to saline without cycloheximide for 24 hr. Under these conditions, we would not expect the steadystate levels of the precursors to change because PI and P2 synthesis can continue. The OD associated with Pl and P2 therefore should not be diminished. This is confirmed in the lower panel of Figure 6 .
Calcium-dependent release of the APRPs
The demonstration of co-synthesis of the APRPs and the AKH peptides suggests that the APRPs may be hormones. Questions * Biosynthesis of Insect Neuropepti des tK+ tK+ zero Ca*+ 5dCa2+ et al., 1984; Pannabecker and Orchard, 1987) . Our own release experiments show that the AKFIs are co-released with the APRPs (not shown).
Discussion
Our results provide evidence for the existence of 2 new peptides derived from the 2 precursors of the AIUI peptides. That PI and P2 are precursors of AKH I and AKH II is based on 2 types of evidence. First, pulse-chase experiments show that tryptophan incorporated into PI and P2 is recovered in AKH I and AKH II after processing. Second, Pl and P2 cross-react with an anti-AKH serum. Together these observations strongly support the role of Pl and P2 as AKH precursors (Hekimi and O'Shea, 1987) . The evidence that Pl and P2 are in addition the precursors of APRP 1 and APRP 2 is derived from a series of quantitiative pulse-chase experiments. In summary, the P 1 and P2 precursors incorporate tyrosine, an amino acid absent from the AKHs. The incorporated tyrosine can be recovered in the 2 identified APRPs when translation, but not processing, is blocked. No other tyrosine-labeled compound besides Pl and P2 can account for the amount of label appearing in the APRPs following a pulse-chase experiment. Thus, Pl and P2, the AKI-I precursors, appear to be the only candidates for the precursors of the APRPs. The strategy summarized above for the discovery of novel products of hormone precursor processing is perhaps possible only with a highly homogenous cell population such as found in the glandular lobes of the CC. In addition to providing evidence that the APRPs are derived from the AKH precursors, we also show that they are major fragments oftheir parent polypeptides. In fact, our size estimates show that Pl and P2 can each accommodate only 1 APRP and 1 but not more than 2 AKH sequences. The estimated size of Pl and P2 (8.4 kDa) can accommodate very little more. The issue of the APRP and AKH content of the precursors will be resolved unambiguously only by determination of the complete amino acid sequences of Pl and P2. Sequencing work on the Ps and APRPs is in progress (S. Hekimi and M. O'Shea, unpublished observations) and results confirm the predictions from the pulse-chase experiments reported here.
A reverse-phase chromatogram of extracts of the glandular cells of the CC shows only 4 major OD peaks. Two of these are AKII I and AKH II. The other 2 major OD peaks are the APRPs. Our present results show that 2 minor OD peaks are associated with PI and P2. The amplitudes ofthese peaks reflect the steadystate levels of these precursors. Since precursors are not terminal products but metabolic intermediates, Pl and P2 do not accumulate and their steady-state levels would be expected to be low. In contrast, the 2 AKHs and the 2 APRPs are accumulating stored products of biosynthesis and are thus present in large amounts and generate the major OD peaks of the CC extract.
Several important questions remain to be addressed following our identification of APRPs in the locust CC. What, for example, are their functions? We know from other systems that peptide precursors often contain sequences of more than. one type of biologically active peptide. Perhaps Pl and P2 are not exceptional in this respect, and the APRPs are peptide hormones with as yet undetermined biological activity. At present, the APRPs remain putative hormones as they were identified by a strategy in which biological activity was not used as a guide for purification. The AKHs and APRPs are however co-released by elevated potassium saline. Thus, the APRPs might be released at the initiation of flight behavior, as are the AKHs, and they may also be involved in regulating physiological functions important in that behavior.
